Cheminformatic Tools and Databases for Pharmacology

session 76374 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M DEUCRAVACITINIB (is an active metabolite)

DEUCRAVACITINIB


ATC L04AF07

IMMUNOSUPPRESSANTS
IMMUNOMODULATING AGENTS
TYROSINE KINASE 2 (TYK2) ALLOSTERIC INHIBITOR
TREATMENT OF ADULTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
BMT-153261 ACCOUNTS FOR APPROXIMATELY 20 PERCENT OF THE SYSTEMIC EXPOSURE

-

Cmax 12.1 NANOMOLAR

TYROSINE KINASE 2 (TYK2)

tyrosine kinase 2 (TYK2) UNIPROT P29597

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |